ELL3
Basic information
Region (hg38): 15:43772605-43777315
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 1 | 0 |
Variants in ELL3
This is a list of pathogenic ClinVar variants found in the ELL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-43773199-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
15-43773339-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
15-43774204-C-T | not specified | Likely benign (Aug 30, 2021) | ||
15-43774212-T-G | not specified | Uncertain significance (Dec 23, 2022) | ||
15-43774612-A-C | not specified | Uncertain significance (Jul 20, 2022) | ||
15-43774625-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
15-43774740-C-G | not specified | Uncertain significance (Mar 15, 2024) | ||
15-43774770-G-A | not specified | Uncertain significance (Jun 30, 2023) | ||
15-43775311-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
15-43775317-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
15-43775344-C-G | not specified | Uncertain significance (Nov 20, 2023) | ||
15-43775541-C-T | not specified | Uncertain significance (May 20, 2024) | ||
15-43775585-C-T | not specified | Uncertain significance (May 09, 2022) | ||
15-43775597-T-A | not specified | Uncertain significance (Mar 20, 2023) | ||
15-43775804-G-C | not specified | Uncertain significance (Feb 12, 2024) | ||
15-43775821-G-T | not specified | Uncertain significance (Aug 23, 2021) | ||
15-43775857-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
15-43775918-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
15-43776135-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
15-43776544-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
15-43776783-C-A | not specified | Uncertain significance (Feb 05, 2024) | ||
15-43776784-A-C | not specified | Uncertain significance (Dec 07, 2021) | ||
15-43776786-T-A | not specified | Uncertain significance (Aug 17, 2021) | ||
15-43776868-G-C | not specified | Uncertain significance (Nov 29, 2023) | ||
15-43776886-C-G | not specified | Uncertain significance (Jan 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ELL3 | protein_coding | protein_coding | ENST00000319359 | 11 | 4944 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.70e-12 | 0.200 | 125653 | 0 | 94 | 125747 | 0.000374 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.470 | 196 | 215 | 0.910 | 0.0000110 | 2552 |
Missense in Polyphen | 62 | 76.261 | 0.813 | 902 | ||
Synonymous | 0.546 | 71 | 77.1 | 0.921 | 0.00000341 | 768 |
Loss of Function | 0.908 | 21 | 26.0 | 0.808 | 0.00000119 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000750 | 0.000750 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000415 | 0.000413 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000492 | 0.000490 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Enhancer-binding elongation factor that specifically binds enhancers in embryonic stem cells (ES cells), marks them, and is required for their future activation during stem cell specification. Does not only bind to enhancer regions of active genes, but also marks the enhancers that are in a poised or inactive state in ES cells and is required for establishing proper RNA polymerase II occupancy at developmentally regulated genes in a cohesin-dependent manner. Probably required for priming developmentally regulated genes for later recruitment of the super elongation complex (SEC), for transcriptional activation during differentiation. Required for recruitment of P-TEFb within SEC during differentiation. Probably preloaded on germ cell chromatin, suggesting that it may prime gene activation by marking enhancers as early as in the germ cells. Promoting epithelial-mesenchymal transition (EMT) (By similarity). Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968). {ECO:0000250, ECO:0000269|PubMed:10882741, ECO:0000269|PubMed:22195968}.;
- Pathway
- Gene expression (Transcription);RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.0831
Intolerance Scores
- loftool
- 0.925
- rvis_EVS
- 0.49
- rvis_percentile_EVS
- 79.38
Haploinsufficiency Scores
- pHI
- 0.0925
- hipred
- N
- hipred_score
- 0.394
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.963
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ell3
- Phenotype
Gene ontology
- Biological process
- DNA-templated transcription, elongation;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;spermatogenesis;regulation of epithelial to mesenchymal transition;positive regulation of DNA-templated transcription, elongation;snRNA transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;stem cell differentiation;positive regulation of neurogenesis;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of neural precursor cell proliferation
- Cellular component
- nucleus;nucleoplasm;nucleolus;transcription elongation factor complex
- Molecular function
- protein binding;enhancer binding